Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Mikol

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Chemical Information and Modeling|July 14, 2012
Engineering protein therapeutics: predictive performances of a structure-based virtual affinity maturation protocolMichael Oberlin, Romano Kroemer, Vincent Mikol, et al.
The Journal of Biological Chemistry|February 12, 2005
Escherichia coli FolC structure reveals an unexpected dihydrofolate binding site providing an attractive target for anti-microbial therapyMagali Mathieu, Guy Debousker, Sophie Vincent, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Variations in the colchicine-binding domain provide insight into the structural switch of tubulinAudrey Dorléans, Benoît Gigant, Raimond B G Ravelli, et al.
The British Journal of Dermatology|May 3, 2025
Efficacy and Safety of Rilzabrutinib in Patients With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Proof-of-Concept Phase II Clinical TrialLeon Kircik, Athanasios Tsianakas, Fernando Valenzuela, et al.
JAMA Dermatology|April 23, 2025
Rilzabrutinib in Antihistamine-Refractory Chronic Spontaneous Urticaria: The RILECSU Phase 2 Randomized Clinical TrialAna Giménez-Arnau, Silvia Ferrucci, Moshe Ben-Shoshan, et al.
ACS Omega|May 31, 2021
Peptidomics of <i>Haemonchus contortus</i>Armelle Buzy, Camille Allain, John Harrington, et al.
Journal of Molecular Biology|July 20, 2002
The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agentsJean-Pierre Guilloteau, Magali Mathieu, Carmela Giglione, et al.
Journal of Medicinal Chemistry|February 21, 2003
Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocketSébastien Maignan, Jean-Pierre Guilloteau, Yong Mi Choi-Sledeski, et al.
The Lancet. Respiratory Medicine|April 5, 2026
Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 studyJorge F Maspero, Ian D Pavord, Michael E Wechsler, et al.
Mabs|March 18, 2016
CODV-Ig, a universal bispecific tetravalent and multifunctional immunoglobulin format for medical applicationsAnke Steinmetz, François Vallée, Christian Beil, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Chemical Information and Modeling|July 14, 2012
Engineering protein therapeutics: predictive performances of a structure-based virtual affinity maturation protocolMichael Oberlin, Romano Kroemer, Vincent Mikol, et al.
The Journal of Biological Chemistry|February 12, 2005
Escherichia coli FolC structure reveals an unexpected dihydrofolate binding site providing an attractive target for anti-microbial therapyMagali Mathieu, Guy Debousker, Sophie Vincent, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 12, 2009
Variations in the colchicine-binding domain provide insight into the structural switch of tubulinAudrey Dorléans, Benoît Gigant, Raimond B G Ravelli, et al.
The British Journal of Dermatology|May 3, 2025
Efficacy and Safety of Rilzabrutinib in Patients With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Proof-of-Concept Phase II Clinical TrialLeon Kircik, Athanasios Tsianakas, Fernando Valenzuela, et al.
JAMA Dermatology|April 23, 2025
Rilzabrutinib in Antihistamine-Refractory Chronic Spontaneous Urticaria: The RILECSU Phase 2 Randomized Clinical TrialAna Giménez-Arnau, Silvia Ferrucci, Moshe Ben-Shoshan, et al.
ACS Omega|May 31, 2021
Peptidomics of <i>Haemonchus contortus</i>Armelle Buzy, Camille Allain, John Harrington, et al.
Journal of Molecular Biology|July 20, 2002
The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agentsJean-Pierre Guilloteau, Magali Mathieu, Carmela Giglione, et al.
Journal of Medicinal Chemistry|February 21, 2003
Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocketSébastien Maignan, Jean-Pierre Guilloteau, Yong Mi Choi-Sledeski, et al.
The Lancet. Respiratory Medicine|April 5, 2026
Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 studyJorge F Maspero, Ian D Pavord, Michael E Wechsler, et al.
Mabs|March 18, 2016
CODV-Ig, a universal bispecific tetravalent and multifunctional immunoglobulin format for medical applicationsAnke Steinmetz, François Vallée, Christian Beil, et al.
Pageof 3